Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature

Marie-Annick Buendia¹, Carolina Armengol^{2

3}, Stefano Cairo⁴

Affiliations

¹ INSERM U1193, Hepato-Biliary Center, Paul Brousse Hospital, Villejuif, France.
² Childhood Liver Oncology Group (c-LOG), Program of Predictive and Personalized Medicine of Cancer (PMPCC), Health Sciences Institute Germans Trias i Pujol (IGTP), Campus Can Ruti, Badalona, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red, CIBERehd, Madrid, Spain.
⁴ Research and Development Department, XenTech, Évry, France.

Comment

Marie-Annick Buendia et al. Hepatology. 2017 Oct.

. 2017 Oct;66(4):1351-1352.

doi: 10.1002/hep.29262. Epub 2017 Aug 26.

Marie-Annick Buendia¹, Carolina Armengol^{2

3}, Stefano Cairo⁴

¹ INSERM U1193, Hepato-Biliary Center, Paul Brousse Hospital, Villejuif, France.
² Childhood Liver Oncology Group (c-LOG), Program of Predictive and Personalized Medicine of Cancer (PMPCC), Health Sciences Institute Germans Trias i Pujol (IGTP), Campus Can Ruti, Badalona, Barcelona, Spain.
³ Centro de Investigación Biomédica en Red, CIBERehd, Madrid, Spain.
⁴ Research and Development Department, XenTech, Évry, France.

No abstract available

Comment on

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.
Sumazin P, Chen Y, Treviño LR, Sarabia SF, Hampton OA, Patel K, Mistretta TA, Zorman B, Thompson P, Heczey A, Comerford S, Wheeler DA, Chintagumpala M, Meyers R, Rakheja D, Finegold MJ, Tomlinson G, Parsons DW, López-Terrada D. Sumazin P, et al. Hepatology. 2017 Jan;65(1):104-121. doi: 10.1002/hep.28888. Epub 2016 Nov 29. Hepatology. 2017. PMID: 27775819